Latest Annual Reports
by Mike Gee
24 May 2026









































Atea Pharmaceuticals, Inc.
REVENUE
N/A
INCOME
-$158,349,000
5.96%
EMPLOYEES
55
CUSTOMERS
N/A
Atea Pharmaceuticals is a late-stage clinical biopharmaceutical company developing oral nucleos(t)ide-based antivirals—primarily the HCV regimen bemnifosbuvir+ruzasvir and HEV candidate AT-587—targeting single-stranded RNA viruses.
View Company PageFiled: 2026-03-05
ADIAL PHARMACEUTICALS, INC.
REVENUE
N/A
INCOME
-$7,977,171
39.56%
EMPLOYEES
6
CUSTOMERS
N/A
Clinical-stage biopharmaceutical company developing AD04 (ondansetron) for genotype-guided treatment of Alcohol Use Disorder, paired with a companion diagnostic.
View Company PageFiled: 2026-03-05
Ambiq Micro, Inc.
REVENUE
$72,514,000
-4.67%
INCOME
-$36,500,000
7.97%
EMPLOYEES
202
CUSTOMERS
200
Ambiq is a public fabless semiconductor company that designs ultra-low-power SoCs and supporting software using its SPOT sub-threshold/near-threshold platform for energy-efficient edge AI compute.
View Company PageFiled: 2026-03-05
BCP Investment Corp
REVENUE
$61,152,000
-2.05%
INCOME
$25,132,000
4.53%
EMPLOYEES
N/A
CUSTOMERS
108
Externally managed, non‑diversified closed‑end business development company (BDC) focused on middle‑market lending and credit strategies (senior secured loans, mezzanine debt, selective equity, CLO exposure and joint ventures), advised by Sierra Crest Investment Management LLC (an affiliate of BC Partners).
View Company PageFiled: 2026-03-05
ALERUS FINANCIAL CORP
REVENUE
N/A
INCOME
$17,439,000
-1.92%
EMPLOYEES
N/A
CUSTOMERS
N/A
Regional bank engaged in mortgage and consumer lending, investment securities management, and deposit/borrowing activities (includes loans held for sale, FHLB transactions, BOLI, and securitization-related items).
View Company PageFiled: 2026-03-04
BIOLARGO, INC.
REVENUE
$7,765,000
-56.32%
INCOME
-$15,189,000
-249.41%
EMPLOYEES
46
CUSTOMERS
N/A
BioLargo, Inc. is a diversified cleantech company that invents, develops, and commercializes technologies for air quality, water treatment, long-duration energy storage, and medical wound care through subsidiaries, partnerships, licensing, joint ventures, and IP sales.
View Company PageFiled: 2026-03-04
FIRST FINANCIAL CORP /IN/
REVENUE
$261,840,000
20.24%
INCOME
$79,208,000
67.55%
EMPLOYEES
946
CUSTOMERS
N/A
First Financial Corporation is a Terre Haute, Indiana–based financial holding company whose primary operating subsidiary is First Financial Bank, N.A., providing commercial, consumer, mortgage, trust and depository services across Indiana, Illinois, Kentucky, Tennessee and Georgia.
View Company PageFiled: 2026-03-04
Black Rock Coffee Bar, Inc.
REVENUE
$200,321,000
24.49%
INCOME
-$16,539,000
-130.12%
EMPLOYEES
2,800
CUSTOMERS
N/A
Black Rock Coffee Bar, Inc. is a holding company that operates a rapidly expanding, company-operated drive-thru coffee bar platform in the Western U.S. and Texas with in-house roasting and a branded Fuel energy drink line following its 2025 IPO.
View Company PageFiled: 2026-03-04
Archimedes Tech SPAC Partners II Co.
REVENUE
N/A
INCOME
$7,986,738
10248.33%
EMPLOYEES
2
CUSTOMERS
N/A
A Cayman Islands‑incorporated blank‑check company (SPAC) formed to complete a business combination—primarily targeting technology sectors (AI, cloud services, automotive technology)—that has not conducted operating activities or generated revenue to date.
View Company PageFiled: 2026-03-04
26North BDC, Inc.
REVENUE
$113,730,000
205.64%
INCOME
$46,969,000
227.79%
EMPLOYEES
150
CUSTOMERS
N/A
26North BDC, Inc. is an externally managed, non-diversified business development company focused on directly originated U.S. middle-market loans seeking current income with some capital appreciation and managed by 26North Direct Lending.
View Company PageFiled: 2026-03-04
ASPAC III Acquisition Corp.
REVENUE
N/A
INCOME
$1,343,931
693.65%
EMPLOYEES
1
CUSTOMERS
N/A
A SPAC formed to identify and consummate a Business Combination in ESG and material technology sectors; as of 12/31/2025 it had no operating business, $60,000,000 in a trust, and a planned Acquisition Merger with Bioserica/PubCo valued at approximately $217,860,000.
View Company PageFiled: 2026-03-04
European Wax Center, Inc.
REVENUE
$207,000,000
-4.61%
INCOME
$12,000,000
-20.00%
EMPLOYEES
196
CUSTOMERS
23,000,000
European Wax Center, Inc. is a leading U.S. franchisor and operator of out-of-home waxing centers delivering licensed esthetician-performed waxing services and proprietary retail products through a largely franchisee-owned, tech-enabled network.
View Company Page